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Breast Cancer Gene Isolated
A team ofresearchers at the NIEHS, in col-
laboration with researchers at the University
of Utah Medical Center, have isolated
BRCAJ, a gene that plays a major role,4
inherited breast cancer and ovarian
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It has been known for years that the
mutant form of BRCAJ, which is located
on human chromosome 17, predisposes
women to breast and ovarian cancers.
However, the NIEHS and University of
Utah researchers are the first to pinpoint
the exact location ofBRC41 and clone it in
the laboratory. Using a technique known
as positional cloning, the researchers creat-
ed a detailed map of 17q, the area of the
chromosome that contains the breast can-
cer gene. They then focused on genes in
that area expressed in normal breast tissue
and compared them with mutational dam-
age in tissue from women known to carry
the defective form ofBRCAJ.
Five percent of breast cancer cases are
due to inherited susceptibilities including-
BRCAJ. Studies of families with defecti*'
BRCA1 genes suggest that more that h
the women who carry the gene willte.
diagnosed with breast cancer by age 5v
and 85% will be diagnosed by age 70.-
Although men in predisposed families also
carry the mutant gene, their risk of breast
cancer is not significantly increased. Now
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Most women have no family history of
breast cancer. It has been thought that
"sporadic" breast cancers may invqlve;
somatic mutations of BRCA 4
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*$. ..is not the only gene involved in
fafilj4breast cancer. BRCA2, which has
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Gene team. NIEHS Director Kenneth Olden (left) with senior members ofthe NIEHS team that identified the
breast cancersusceptibility gene (leftto right): J. Carl Barrett, RogerW.Wiseman, and Andrew Futreal.
recently been mapped to chromosome 13,
has not yet been isolated. However,
BRCA2, unlike BRCA1, is not implicated
an cancer.
eased risk for breast cancer has
Mbserved in families with Li-
syndrome, which is linked to
( the p53 tumor-suppressor
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c4I?B1 gene.
Althouh the isolation of BRCAJ has
n;ii;iSnw4iate iiplications for breast can-
cer screenng and treatment in the general
p atii isignificantly advances the
lng4term goal of research to mitigate
gtic dTSilefects. Existing tests for the muta-
are used only in individuals from fam-
il0es known to carry the defective gene.
Isolaton of the gene may lead to develop-
ment of tests for the gene itself rather than
based on genetic markers. Such a test
*Wd have to be able to identify a variety
bfmutations spread widely across the gene.
Untdl BRCAJ is better understood, testing
for mutations will be limited to research to
learn more about the gene.
The introduction of genetic testing
into mainstream medical practice has been
a major priority issue for the Ethical, Legal,
Ind Social Implications program of the
Human Genome Project. In addition, a
task force on genetic testing is being set up
by the Department ofHealth and Human
Services to consider these issues. The task
force will include consumers, geneticists,
government officials, and biotechnologists.
In the meantime, a woman with a fam-
ily history ofbreast cancer, especially ifthe
cancers were diagnosed at a young age,
should discuss early detection procedures
for breast cancer with her doctor.
NIEHS Launches
Clearinghouse
Where do people go when they have ques-
tions about environmental health and
related issues? Beginning October 1994,
the National Institute of Environmental
Health Sciences in Research Triangle Park,
NC, will provide a major, national infor-
mation source and referral point for ques-
tions about health and the environment
with the establishment ofEnviroHealth, an
environmental health information clearing-
house, accessible toll-free through 1-800-
NIEHS94 (643-4794).
Kenneth Olden, NIEHS director, has
given the clearinghouse top priority and
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